NOS3 and Alzheimer disease: We could conclude that WZY compounds affect AD primarily through binding to node proteins of serotonergic synapse signaling (SLC6A4), hormones (PTGS2, ESR1, AR), inflammation (SRC, TNF, NOS3), transcription regulation (NR3C1), and molecular chaperones (HSP90AA1).